Polyketides and their synthesis and use
AssigneeBiotica Technology Limited
InventorsPeter Francis Leadlay, James Staunton, Lake Ee Khaw
Life of this patent
Estimating the term…
Abstract
The rapamycin gene cluster is an example of a gene cluster which includes a gene (rapL) leading to the formation of a precursor compound (pipecolic acid, in this case) which is required for inclusion in the larger product (rapamycin) produced by the enzymes encoded by the cluster. We have produced a mutant strain containing a rapamycin gene cluster in which the rapL gene is disabled. The strain does not naturally produce rapamycin but does so if fed with pipecolic acid. By feeding with alternative carboxylic acids we have produced variants of rapamycins. Tests have shown biological activity.
Claims2
A process for producing an analogue of rapamycin in which an L-pipecolate moiety is substituted by a moiety derived from a precursor compound selected from the group consisting of L-proline, L-trans-4-hydroxyproline, L-cis-4-hydroxyproline, L-cis-3-hydroxyproline and trans-3-aza-bicyclohexane-2-carboxylic acid, said process comprising:
- a) a step of modifying the gene cluster for the production of rapamycin in a host microorganism, wherein said microorganism is S. hygroscopicus, said gene cluster including a gene, said gene being the rap L gene which encodes the enzyme which is responsible for the production of L-pipecolate which is incorporated into rapamycin, said step comprising the step of deleting or inactivating said rap L gene;
- and
- b) a step of culturing said host microorganism in the presence of said precursor compound to effect synthesis of said analogue of raparnycin, whereby said precursor compound is incorporated in said synthesis and said rapamycin analogue is produced.
Dependencies are inferred from the claim text.